Advisory & Reminder News

TULSA, Okla.--(BUSINESS WIRE)--Helmerich & Payne, Inc. (NYSE: HP) today announced that John Lindsay, President and Chief Executive Officer; Kevin Vann, Senior Vice President and Chief Financial Officer; and Todd Scruggs, Vice President of Finance & Treasury plan to participate in the following investor conferences during the month of September 2025. Participation by the management team will vary by event. The Barclays 39th Annual Energy-Power Conference on Tuesday and Wednesday, Septemb...

BEAVERTON, Ore.--(BUSINESS WIRE)--NIKE, Inc. (NYSE: NKE) plans to release its first quarter fiscal 2026 financial results on Tuesday, September 30, 2025, at approximately 1:15 p.m. PT, following the close of regular stock market trading hours. Following the news release, NIKE, Inc. management will host a conference call beginning at 2:00 p.m. PT to review results. The conference call will be broadcast live over the Internet and can be accessed at https://investors.nike.com/. For those unable to...

ESTERO, Fla.--(BUSINESS WIRE)--Hertz Global Holdings, Inc. (NASDAQ: HTZ) (the “Company”) announced today that it plans to report its third quarter 2025 financial results at 8:00 a.m. ET on Tuesday, November 4, 2025, followed by an earnings call at 9:00 a.m. ET. A live webcast of the call will be available on the Investor Relations page of the Company’s website at https://ir.hertz.com. To access the call by phone, please register through this link: Hertz Q3 2025 earnings teleco registration, and...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the release of its half-year financial results, originally scheduled for September 19, 2025, has been postponed to September 29, 2025, after the market clos...

BURBANK, Calif.--(BUSINESS WIRE)--Jimmy Pitaro, Chairman, ESPN, The Walt Disney Company (NYSE: DIS), will participate in a question-and-answer session at the Bank of America Media, Communications & Entertainment Conference on Thursday, September 4, 2025 at approximately 1:10 p.m. ET/ 10:10 a.m. PT. To stream live, please visit www.disney.com/investors. A recording of the question-and-answer session will be archived on our website....

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike Holdings, Inc. (Nasdaq: CRWD), today announced that it will host a briefing for investors on September 17, 2025 during its Fal.Con 2025 customer conference. Event: CrowdStrike Investor Briefing Location: Las Vegas Date: Wednesday, September 17, 2025 Presentation time: 11:00 a.m. PDT Space for the event is limited and pre-registration is required. Analysts and investors interested in attending are encouraged to contact Investor Relations at investors@c...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced that the company will have multiple cebranopadol presentations during the upcoming PAINWeek Annual Meeting, taking place on September 2-5, 2025, in Las Vegas, Nevada. The positive Phase 3 pivotal trial results will be presented as a Scientific Abstract Oral presentation to highlight data supporting cebranopadol, currently under development, as a much-needed novel tre...

NEW YORK--(BUSINESS WIRE)--VEON Ltd. (Nasdaq: VEON), a global digital operator and Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW), a leading telecommunications and digital operator in Ukraine (“Kyivstar”), announced today that Kyivstar will host an investor meeting on Thursday, August 28, 2025, from 10:00 AM to 11:30 AM Eastern Time. The meeting will provide an update on Kyivstar’s strategic initiatives, financial performance, and market outlook. Members of the senior management team will present ke...

HERZLIYA, Israel--(BUSINESS WIRE)--Cognyte Software Ltd. (NASDAQ: CGNT), a global leader in software-driven technology for investigative analytics, today announced it will conduct a conference call on Tuesday, September 9, 2025, at 8:30am ET to review its second quarter fiscal 2026 financial results for the quarter ending July 31, 2025. An earnings press release will be issued prior to the conference call. A real-time webcast of the conference call with presentation slides will be available in...

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announced that Mary Szela, Chief Executive Officer and President, and David Patience, Chief Financial Officer, will participate in the foll...